Bio surgery Market size is estimated to reach $16.1 Billion by 2025 and is poised to grow at a CAGR of 5.95% during the forecast period 2020-2025. Bio surgery is an emerging field which is a type of surgical procedure that involves the use of various natural and artificially produced surgical products. These products are used to isolate the wound and prevent blood loss by soaking fluids and closing the wound. Implementation of these products helps with problems associated with surgeries and helps reduce the time required after treatment. Growing aging population, surgeries in sports-related and trauma injuries are major factors driving the market growth over the forecast period (2020-2025).
Key Takeaways
- Geographically, the North America is poised to see extraordinary development owing to well-developed healthcare system, increasing volume of surgeries performed, large number of hospitals and is set to continue during the forecast period (2020-2025).
- Increasing demand for innovative product development and experimentation for blood loss management in patients undergoing surgery is one of the factor driving the market
- The high cost associated with surgeries, the tight regulatory environment for product approval, and the growing popularity of minimally invasive surgeries are likely to limit its growth in various regions.
- Detailed analysis on the Strength, Weakness and Opportunities of the prominent players operating in the market is set to be provided in the Bio surgery Market report.
By Application Type- Segment Analysis
The global Bio surgery market based on the application has Cardiovascular and thoracic surgery, General surgery, Gynecological surgery, Neuro and spine surgery, orthopedic surgery, Urological surgery. The Orthopedic Surgery segment is projected to have the largest share of the Bio surgery market over the forecast period. Most of the orthopedic bone and soft tissue repair surgeries are performed worldwide in this section. The Market is set to grow with the highest CAGR of 4.9% during the forecast period owing to the increase in demand for innovative surgical procedures.
By Product – Segment Analysis
The Bio surgery market based on product has Hemostatic agents, surgical sealing agents, Bone graft substitute, Soft tissue management, Staple-Line Reinforcement agents and others. In the products segment, the surgical sealants and adhesives segment is poised to grow at the highest CAGR over the forecast period (2020-2025) owing to increase in number of surgeries, owing to the increasing application of various surgical procedures in the soft tissue attachment department, it is estimated to record a faster CAGR over the forecast period.
By Geography - Segment Analysis
North America dominates the geography segment of Bio surgery Market with a share of more than 39.1% in 2019. This is owing to its well-established healthcare sectors. The adoption of advanced surgical instruments and equipment is set to create growth opportunities for the regional market in the near future. Europe is estimated to capture the second largest market share in the forecast period owing to an increase in aging populations suffering from various illnesses. With the improved innovative technologies, the market is poised to grow at the highest CAGR over the forecast period (2020-2025).
Drivers – Bio surgery Market
- Increasing volume of surgeries
The Bio surgery market is poised to grow owing to increasing number of surgeries performed every year. In addition, there is on bio surgery treatment owing to growth in sport and spinal cord injuries. Innovation in technology is set to create more demand for Vasculitis Treatment, and hence help in market growth in upcoming years.
Challenges – Bio surgery Market
The main challenge of this market is the cost of obtaining treatment that affects the expansion of the Bio surgery market. The cost of surgical procedures has increased significantly over the years owing to the consolidation of health care providers and the rising costs of using complex medical procedures. This is projected to hinder market growth over the forecast period.
Bio surgery Market Industry outlook:
Product launches, mergers and acquisitions, joint ventures and R&D activities are key strategies adopted by players in the Bio surgery Market. Key companies of this market include Baxter International Inc. (US), C.R. Bard, Johnson & Johnson (US), and Medtronic plc. Sonodi Group, B. Braun Melsungen AG, MAQUET Holding B.V & Co. KG, Cryolife Inc. Stryker Corporation, Hemostasis LLC, TELA BIO, Agro Bio surgery Ltd, Pfizer Inc, Integra Lifesciences Holdings Corporation, Cohera Medical Inc. Pfizer Inc. CSL Limited.
Acquisitions/Product Launches:
- In May 2019, TELA Bio and Agro Bio surgery limited announced that they had received “CE” mark for the commercial sale of “OviTex Reinforced Bio Scaffold”.
- In February 2019, Tissue Regenix announced that they had launched a separate division for its Bio surgery market.
